Pluri Inc. (PLUR)
Pluri Inc. (PLUR) Stock Price, Analysis & Data
Keine Daten verfügbar
| Geld | 1.66 |
| Marktkapitalisierung | 17.26 Mio |
| Umsatz (TTM) | 1.08 Mio |
| Nettogewinn (TTM) | -25.54 Mio |
| Beta | 0.68 |
| EPS (ttm) | -2.9 |
| KGV (TTM) | n/a |
| Forward-KGV | -0.84 |
| KBV (TTM) | -0.90 |
| KUV (TTM) | 16.00 |
| Earnings Date | n/a |
| Brief | 1.8 |
| Volumen | 48,570 |
| Ø Vol. (20D) | 26,513 |
| Eröffnung | 1.63 |
| Vortagesschluss | 1.60 |
| Tagesspanne | 1.55 - 1.67 |
| 52-Wk Range | 1.45 - 5.68 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über PLUR
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. Its product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal ce...
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Pluri 1.34 Mio, ein Anstieg von 309.82% im Vergleich zum Vorjahr (326K). Der Gewinn lag bei -22.58 Mio, ein Anstieg von 8.11 %.
FinanzberichteGewinnüberraschung
vor 2 Monaten · Insider Monkey
Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest InWe just covered the 7 Best Lab-Grown Meat Stocks to Invest In and Pluri Inc. (NASDAQ:PLUR) ranks 4th on this list. Pluri Inc. (NASDAQ:PLUR), through the highly publicized joint venture, Ever After Foo...
